Lv3
328 积分 2025-07-02 加入
Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases: an International Organization for Study of Inflammatory Bowel Diseases consensus
7小时前
已完结
Systematic review: safety of mesalazine in ulcerative colitis
1个月前
已完结
Thromboembolic events and cardiovascular mortality in inflammatory bowel diseases: A meta-analysis of observational studies
1个月前
已完结
Comorbidities in inflammatory bowel disease: a call for action
1个月前
已完结
Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial
1个月前
已完结
Long-term Effectiveness and Safety of Risankizumab in Patients with Crohn’s Disease from a Large Tertiary Center
1个月前
已完结
Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn’s Disease
1个月前
已完结
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis
1个月前
已完结
Epidemiology, risk factors and management of cardiovascular diseases in IBD
1个月前
已完结
皖公网安备34019202002308
